Life sciences

Tile for A cautionary tale: navigating jurisdiction and arbitration in cross‑border life sciences disputes
May 28, 2026

A cautionary tale: navigating jurisdiction and arbitration in cross‑border life sciences disputes

Introduction The continued globalisation of research, development and commercialisation within the life sciences sector has led to a...
Read more
Tile for Introducing S&B Signals: helping you anticipate what’s coming next
May 22, 2026

Introducing S&B Signals: helping you anticipate what’s coming next

In our conversations with clients, a consistent theme is emerging. The volume and pace of legal and regulatory change is increasing,...
Read more
Tile for Life sciences and personal data: adapting to the UK’s updated data protection framework
May 15, 2026

Life sciences and personal data: adapting to the UK’s updated data protection framework

The life sciences sector sits at the intersection of scientific innovation, healthcare delivery and large‑scale data use, making the...
Read more
Tile for The use of AI in the life sciences sector and the implications of GDPR
May 13, 2026

The use of AI in the life sciences sector and the implications of GDPR

Artificial intelligence (AI) systems are increasingly becoming an effective and valuable tool in the life sciences sector. Their...
Read more
Tile for Protecting, leveraging and enforcing IP around the world
May 1, 2026

Protecting, leveraging and enforcing IP around the world

We always value the opportunity created by the INTA Annual Meeting to reconnect with our international lawyer contacts and our clients....
Read more
Tile for From space to science: how in‑orbit manufacturing is reshaping UK life sciences
April 15, 2026

From space to science: how in‑orbit manufacturing is reshaping UK life sciences

As part of its £2bn Life Sciences Sector Plan, the UK government has taken a global lead in announcing new measures to support the...
Read more
Tile for Modernising UK clinical trials: what’s changing from April 2026
April 8, 2026

Modernising UK clinical trials: what’s changing from April 2026

The new UK clinical trials regime will accelerate the approval process for new medicines and enable patients to access treatments sooner...
Read more
Tile for UK government position on text and data mining: what does it mean for the life sciences industry?
March 27, 2026

UK government position on text and data mining: what does it mean for the life sciences industry?

You probably already know that the UK government has “kicked the can down the road” on AI and copyright reform, concluding in its March...
Read more